Exportação concluída — 

Treatment satisfaction and quality of life of adolescents with T1DM using continuous subcutaneous insulin infusion

Bibliographic Details
Main Author: Lima, Lígia
Publication Date: 2022
Other Authors: Silva, Rute, Cardoso, Helena, Martins, Teresa
Format: Article
Language: eng
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: https://doi.org/10.29352/mill0218.25955
Summary: Introduction: Continuous subcutaneous insulin infusion (CSII) has been prioritised in the metabolic control of type 1 Diabetes Mellitus (T1DM) in children and adolescents. Objective: To assess the quality of life and treatment satisfaction in adolescents with T1DM using CSII and analyse the role of quality of life in predicting treatment satisfaction among these adolescents. Methods: The sample comprised 77 adolescents aged 10 to 18, followed-up in two central hospitals in the Northern region of Portugal. The Quality-of-Life questionnaire for treatment with Insulin Infusion Pump – adolescents’ version - and the adapted version for adolescents of treatment satisfaction with Insulin Pump questionnaire were used. Results: Most adolescents reported a good quality of life, with lower values in the dimensions related to the Impact of Diabetes, Feelings and Mood and Leisure. They were satisfied with the CSII system, recognizing it as convenient, easy to use and guarantying autonomy. A prediction model was tested through multiple linear regression, with the Impact of diabetes, Leisure Time and Feelings and mood explaining 32.7% of the variance of treatment satisfaction. Conclusion: CSII is a therapeutic option that adolescents with T1DM perceive to promote their quality of life and consider satisfactory, in line with the previous evidence. However, interventions aimed to support these adolescents in managing their disease and treatment should focus on aspects such as self-image and emotional well-being.
id RCAP_22c64e81636a90fdcf9e7bde74b1e1a4
oai_identifier_str oai:ojs.revistas.rcaap.pt:article/25955
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Treatment satisfaction and quality of life of adolescents with T1DM using continuous subcutaneous insulin infusionSatisfacción con el tratamiento y calidad de vida en adolescentes con DMT1 mediante infusión continua de insulina subcutáneaSatisfação com o tratamento e qualidade de vida em adolescentes com DM1 e sistema de perfusão subcutânea continua de insulinaLife and Healthcare SciencesIntroduction: Continuous subcutaneous insulin infusion (CSII) has been prioritised in the metabolic control of type 1 Diabetes Mellitus (T1DM) in children and adolescents. Objective: To assess the quality of life and treatment satisfaction in adolescents with T1DM using CSII and analyse the role of quality of life in predicting treatment satisfaction among these adolescents. Methods: The sample comprised 77 adolescents aged 10 to 18, followed-up in two central hospitals in the Northern region of Portugal. The Quality-of-Life questionnaire for treatment with Insulin Infusion Pump – adolescents’ version - and the adapted version for adolescents of treatment satisfaction with Insulin Pump questionnaire were used. Results: Most adolescents reported a good quality of life, with lower values in the dimensions related to the Impact of Diabetes, Feelings and Mood and Leisure. They were satisfied with the CSII system, recognizing it as convenient, easy to use and guarantying autonomy. A prediction model was tested through multiple linear regression, with the Impact of diabetes, Leisure Time and Feelings and mood explaining 32.7% of the variance of treatment satisfaction. Conclusion: CSII is a therapeutic option that adolescents with T1DM perceive to promote their quality of life and consider satisfactory, in line with the previous evidence. However, interventions aimed to support these adolescents in managing their disease and treatment should focus on aspects such as self-image and emotional well-being.Introducción: La infusión continua de insulina subcutánea (IICS) ha sido priorizada en el control metabólico de la Diabetes Mellitus tipo 1 (DM1) en niños y adolescentes. Objetivo: Evaluar la calidad de vida y la satisfacción con el tratamiento en adolescentes con DM1 utilizando IICS, y analizar el papel de la calidad de vida en la predicción de la satisfacción con el tratamiento en estos adolescentes. Métodos: Participaram 77 adolescentes, de 10 a 18 años, Se utilizó el cuestionario de Calidad de Vida para el tratamiento con IICS y el cuestionario de satisfacción del tratamiento con IICS. Resultados: La mayoría de los adolescentes reportaron una buena calidad de vida, con valores más bajos en las dimensiones relacionadas con el Impacto de la Diabetes, sentimientos y Estado de Ánimo y Ocio. Están satisfechos con el sistema IICS. A través de la regresión lineal múltiple, se probó un modelo de predicción, con el Impacto de la diabetes, el Tiempo de Ocio y los Sentimientos y el estado de ánimo explicando el 32,7% de la varianza de la satisfacción con el tratamiento. Conclusión: La IICS es una opción terapéutica que los adolescentes con DM1 perciben como promotora de su calidad de vida y se sienten como satisfactoria, en línea con la evidencia previa. Sin embargo, las intervenciones dirigidas a apoyar a estos adolescentes para manejar su enfermedad y tratamiento deben centrarse en aspectos como la autoimagen y el bienestar emocional.Introdução: O sistema de perfusão subcutânea contínua de insulina (PSCI) tem sido priorizado no controlo metabólico de crianças e jovens com Diabetes Mellitus tipo 1 (DM1). Objetivo: Avaliar a qualidade de vida e a satisfação com o tratamento em adolescentes com DM1 que utilizam o sistema PSCI; Analisar o papel da qualidade de vida na predição da sua satisfação com o tratamento. Métodos: Participaram 77 adolescentes, entre os 10 e os 18 anos. Utilizaram se dois questionários, um sobre Qualidade de vida associada ao tratamento com PSCI e outro sobre Satisfação com este tipo de tratamento. Resultados: Os adolescentes tendem, maioritariamente a manifestar uma boa qualidade de vida, com valores mais baixos nas dimensões relativas ao Impacto da Diabetes, Sentimentos e Humor e Tempos Livres. Estão ainda satisfeitos com o sistema PSCI.. Através da regressão linear múltipla, testou-se um modelo de predição, tendo o Impacto da diabetes, os Tempos livres e os Sentimentos e humor explicado 32,7% da variância da Satisfação com o tratamento com PSCI. Conclusão: O uso da PSCI é uma resposta terapêutica que os adolescentes com DM1 percebem como promotora da sua qualidade de vida e globalmente satisfatória, o que vai ao encontro da evidência. Porém, na promoção da adaptação à doença e regime terapêutico, aspetos como as implicações na autoimagem e a gestão emocional devem ser domínios de especial atenção.Polytechnic Institute of Viseu (IPV)2022-05-31info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttps://doi.org/10.29352/mill0218.25955eng1647-662X0873-3015Lima, LígiaSilva, RuteCardoso, HelenaMartins, Teresainfo:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2023-06-15T15:02:11Zoai:ojs.revistas.rcaap.pt:article/25955Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T10:06:18.868358Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Treatment satisfaction and quality of life of adolescents with T1DM using continuous subcutaneous insulin infusion
Satisfacción con el tratamiento y calidad de vida en adolescentes con DMT1 mediante infusión continua de insulina subcutánea
Satisfação com o tratamento e qualidade de vida em adolescentes com DM1 e sistema de perfusão subcutânea continua de insulina
title Treatment satisfaction and quality of life of adolescents with T1DM using continuous subcutaneous insulin infusion
spellingShingle Treatment satisfaction and quality of life of adolescents with T1DM using continuous subcutaneous insulin infusion
Lima, Lígia
Life and Healthcare Sciences
title_short Treatment satisfaction and quality of life of adolescents with T1DM using continuous subcutaneous insulin infusion
title_full Treatment satisfaction and quality of life of adolescents with T1DM using continuous subcutaneous insulin infusion
title_fullStr Treatment satisfaction and quality of life of adolescents with T1DM using continuous subcutaneous insulin infusion
title_full_unstemmed Treatment satisfaction and quality of life of adolescents with T1DM using continuous subcutaneous insulin infusion
title_sort Treatment satisfaction and quality of life of adolescents with T1DM using continuous subcutaneous insulin infusion
author Lima, Lígia
author_facet Lima, Lígia
Silva, Rute
Cardoso, Helena
Martins, Teresa
author_role author
author2 Silva, Rute
Cardoso, Helena
Martins, Teresa
author2_role author
author
author
dc.contributor.author.fl_str_mv Lima, Lígia
Silva, Rute
Cardoso, Helena
Martins, Teresa
dc.subject.por.fl_str_mv Life and Healthcare Sciences
topic Life and Healthcare Sciences
description Introduction: Continuous subcutaneous insulin infusion (CSII) has been prioritised in the metabolic control of type 1 Diabetes Mellitus (T1DM) in children and adolescents. Objective: To assess the quality of life and treatment satisfaction in adolescents with T1DM using CSII and analyse the role of quality of life in predicting treatment satisfaction among these adolescents. Methods: The sample comprised 77 adolescents aged 10 to 18, followed-up in two central hospitals in the Northern region of Portugal. The Quality-of-Life questionnaire for treatment with Insulin Infusion Pump – adolescents’ version - and the adapted version for adolescents of treatment satisfaction with Insulin Pump questionnaire were used. Results: Most adolescents reported a good quality of life, with lower values in the dimensions related to the Impact of Diabetes, Feelings and Mood and Leisure. They were satisfied with the CSII system, recognizing it as convenient, easy to use and guarantying autonomy. A prediction model was tested through multiple linear regression, with the Impact of diabetes, Leisure Time and Feelings and mood explaining 32.7% of the variance of treatment satisfaction. Conclusion: CSII is a therapeutic option that adolescents with T1DM perceive to promote their quality of life and consider satisfactory, in line with the previous evidence. However, interventions aimed to support these adolescents in managing their disease and treatment should focus on aspects such as self-image and emotional well-being.
publishDate 2022
dc.date.none.fl_str_mv 2022-05-31
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://doi.org/10.29352/mill0218.25955
url https://doi.org/10.29352/mill0218.25955
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 1647-662X
0873-3015
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Polytechnic Institute of Viseu (IPV)
publisher.none.fl_str_mv Polytechnic Institute of Viseu (IPV)
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833590476922421248